-
Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression
Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P.-P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J. & Michels, M., 15 Oct 2025, In: International Journal of Cardiology. 437, 133444.Research output: Contribution to journal › Article › Academic › peer-review
-
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection
Xiao, Y., Hu, X., Rudolphi, C. F., Nollet, E. E., Nederlof, R., Wang, Q., Bakker, D., Nikolaou, P. E., Knol, J. C., Haas, R. R.G.-D., Henneman, A. A., Pham, T. V., Jimenez, C. R., Grootemaat, A. E., van der Wel, N. N., Girardin, S. E., Kaludercic, N., van der Velden, J., Onódi, Z. & Leszek, P. & 7 others, , Aug 2025, In: Basic Res. Cardiol.. 120, 4, p. 707-725 19 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Metabolic alterations in human hypertrophic cardiomyopathy
Nollet, E. E., Sequeira, V., Maack, C., Ochala, J. & van der Velden, J., 1 Jun 2025, In: Journal of Cardiovascular Aging. 5, 2, 11.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
